A wireless microchip implanted beneath the retina improved vision in 81% of patients with advanced age-related macular ...

New treatments for macular degeneration may help preserve your eyesight for longer, without the need for frequent injections. Some of these treatments include retinal gene therapy and the "port" ...

Many surgeons admit that medical robots can now operate with greater precision than human specialists. However, the complex ...

4D Molecular Therapeutics has sold the Asia-Pacific rights to its eye gene therapy to Otsuka Pharmaceutical, securing $85 ...

Both anti-VEGF and surgical treatments improve VA in AMD-related submacular hemorrhage, with no statistically significant difference between the two treatments. Anti-VEGF injections may be associated ...

The burdens that monthly or every-other-month injections in the eye impose on patients with retinal diseases are well-known to be barriers to care for many people with these conditions. Making ...

A whisper-thin chip, smart glasses and patient training are reshaping how older people live with central vision loss across ...

A tiny chip, smart glasses and months of training are rewriting what blindness means for older people with failing central ...

Retinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy affect millions of people globally, often leading to vision loss with minimal straightforward treatment.

Continuous use of tear substitutes significantly improved dry eye symptoms in patients with neovascular age-related macular degeneration (AMD) who received frequent eye injections, whereas ...

Age-Related Macular Degeneration (AMD) is the biggest cause of sight loss in the UK, affecting around 700,000 people. As February is AMD Awareness Month, Optegra Eye Clinic West London is spotlighting ...